EX-99.1 2 a17-25043_1ex99d1.htm EX-99.1

EXHIBIT 99.1

 

NEWS

 

VEECO REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS

 

Third Quarter 2017 Highlights:

 

·                  Revenues of $131.9 million, compared with $85.5 million in the same period last year

·                  GAAP net loss of $21.9 million, or $0.47 per share

·                  Non-GAAP net income of $4.3 million, or $0.09 per diluted share

 

Plainview, N.Y., November 2, 2017 — Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third fiscal quarter ended September 30, 2017. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

 

U.S. dollars in millions, except per share data

 

GAAP Results

 

Q3 ‘17

 

Q3 ‘16

 

Revenue

 

$

131.9

 

$

85.5

 

Net income (loss)

 

$

(21.9

)

$

(69.6

)

Diluted earnings (loss) per share

 

$

(0.47

)

$

(1.78

)

 

 

 

 

 

 

Non-GAAP Results

 

Q3 ‘17

 

Q3 ‘16

 

Net income (loss)

 

$

4.3

 

$

(1.8

)

Operating income (loss)

 

$

6.8

 

$

(0.2

)

Diluted earnings (loss) per share

 

$

0.09

 

$

(0.05

)

 

“The third quarter of 2017 marked the first full quarter of Veeco and Ultratech on a combined basis.  Sales in the quarter were driven by increased shipments of our MOCVD tools and backlog has continued to build.  Also during the quarter, we formally released our new MOCVD system, the EPIK® 868, which provides a lower-cost and higher-productivity solution for our customers,” commented John R. Peeler, Chairman and Chief Executive Officer.  “The integration of Ultratech into Veeco is proceeding extremely well with many key milestones now behind us, including the complete integration of our sales and support organizations.  As a result, we are even stronger than before, with the right staff in each region, focused on driving improved results for our business and customers.”

 

Guidance and Outlook

 

The following guidance is provided for Veeco’s fourth quarter 2017:

 

·                  Revenue is expected to be in the range of $135 million to $155 million

·                  GAAP net loss is expected to be in the range of ($15) million to ($8) million

·                  Non-GAAP operating income is expected to be in the range of $5 million to $12 million

·                  GAAP earnings (loss) per share are expected to be in the range of ($0.33) to ($0.17)

·                  Non-GAAP earnings (loss) per share are expected to be in the range of $0.00 to $0.16

 

Please refer to the tables at the end of this press release for further details.

 

1



 

Conference Call Information

 

A conference call reviewing these results has been scheduled for today, November 2, 2017 starting at 5:00pm ET. To join the call, dial 800-263-0877 (toll free) or 323-701-0225 and use passcode 7119567. The call will also be webcast live on the Veeco website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

 

About Veeco

 

Veeco (NASDAQ: VECO) is a leading manufacturer of innovative semiconductor process equipment. Our proven MOCVD, lithography, laser annealing, ion beam and single wafer etch & clean technologies play an integral role in producing LEDs for solid-state lighting and displays, and in the fabrication of advanced semiconductor devices.   With equipment designed to maximize performance, yield and cost of ownership, Veeco holds technology leadership positions in all these served markets. To learn more about Veeco’s innovative equipment and services, visit www.veeco.com.

 

Forward-looking Statements

 

To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Management’s Discussion and Analysis sections of Veeco’s Annual Report on Form 10-K for the year ended December 31, 2016 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

 

 

-financial tables attached-

 

Veeco Contacts:

 

 

 

Investors:

Media:

Suzanne Schmidt 516-677-0200 x1272

Jeffrey Pina 516-677-0200 x1222

sschmidt@veeco.com

jpina@veeco.com

 

2


 


 

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

Net sales

 

$

131,872

 

$

85,482

 

$

341,324

 

$

238,842

 

Cost of sales

 

78,811

 

52,027

 

215,344

 

141,991

 

Gross profit

 

53,061

 

33,455

 

125,980

 

96,851

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

Research and development

 

24,061

 

19,892

 

57,669

 

63,545

 

Selling, general, and administrative

 

29,771

 

18,396

 

71,574

 

58,230

 

Amortization of intangible assets

 

12,500

 

5,261

 

21,722

 

15,785

 

Restructuring

 

5,010

 

1,798

 

9,605

 

3,993

 

Acquisition costs

 

783

 

 

16,277

 

 

Asset impairment

 

2

 

56,035

 

1,139

 

69,662

 

Other, net

 

(140

)

795

 

(228

)

884

 

Total operating expenses, net

 

71,987

 

102,177

 

177,758

 

212,099

 

Operating income (loss)

 

(18,926

)

(68,722

)

(51,778

)

(115,248

)

Interest income (expense), net

 

(4,748

)

260

 

(12,368

)

713

 

Income (loss) before income taxes

 

(23,674

)

(68,462

)

(64,146

)

(114,535

)

Income tax expense (benefit)

 

(1,790

)

1,136

 

(24,969

)

2,677

 

Net income (loss)

 

$

(21,884

)

$

(69,598

)

$

(39,177

)

$

(117,212

)

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.47

)

$

(1.78

)

$

(0.91

)

$

(2.99

)

Diluted

 

$

(0.47

)

$

(1.78

)

$

(0.91

)

$

(2.99

)

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

Basic

 

46,941

 

39,131

 

43,100

 

39,193

 

Diluted

 

46,941

 

39,131

 

43,100

 

39,193

 

 

3



 

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

September 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

235,268

 

$

277,444

 

Short-term investments

 

85,853

 

66,787

 

Accounts receivable, net

 

113,795

 

58,020

 

Inventories

 

113,681

 

77,063

 

Deferred cost of sales

 

17,594

 

6,160

 

Prepaid expenses and other current assets

 

36,396

 

16,034

 

Total current assets

 

602,587

 

501,508

 

Property, plant and equipment, net

 

84,403

 

60,646

 

Intangible assets, net

 

383,596

 

58,378

 

Goodwill

 

308,529

 

114,908

 

Deferred income taxes

 

2,528

 

2,045

 

Other assets

 

25,263

 

21,047

 

Total assets

 

$

1,406,906

 

$

758,532

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

53,716

 

$

22,607

 

Accrued expenses and other current liabilities

 

65,728

 

33,201

 

Customer deposits and deferred revenue

 

107,636

 

85,022

 

Income taxes payable

 

4,171

 

2,311

 

Current portion of long-term debt

 

 

368

 

Total current liabilities

 

231,251

 

143,509

 

Deferred income taxes

 

46,268

 

13,199

 

Long-term debt

 

272,825

 

826

 

Other liabilities

 

11,033

 

6,403

 

Total liabilities

 

561,377

 

163,937

 

 

 

 

 

 

 

Total stockholders’ equity

 

845,529

 

594,595

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

1,406,906

 

$

758,532

 

 

4



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)

(unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

Three months ended September 30, 2017

 

GAAP

 

Share-Based
Compensation

 

Amortization

 

Other

 

Non-GAAP

 

Net sales

 

$

131,872

 

 

 

 

 

 

 

$

131,872

 

Gross profit

 

53,061

 

740

 

 

 

1,954

 

55,755

 

Gross margin

 

40.2

%

 

 

 

 

 

 

42.3

%

Research and development

 

24,061

 

(849

)

 

 

 

 

23,212

 

Selling, general, and administrative and Other

 

29,631

 

(3,714

)

 

 

(195

)

25,722

 

Net income (loss)

 

(21,884

)

6,170

 

12,500

 

7,504

 

4,290

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.47

)

 

 

 

 

 

 

$

0.09

 

Diluted

 

(0.47

)

 

 

 

 

 

 

0.09

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

46,941

 

 

 

 

 

 

 

47,107

 

Diluted

 

46,941

 

 

 

 

 

 

 

47,327

 

 

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)

(unaudited)

 

Three months ended September 30, 2017

 

 

 

Restructuring

 

4,143

 

Acquisition related

 

783

 

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

1,856

 

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

293

 

Asset impairment

 

2

 

Non-cash interest expense

 

2,754

 

Non-GAAP tax adjustment *

 

(2,327

)

Total Other

 

7,504

 

 


* - The ‘with or without’ method is utilized to determine the income tax effect of all non-GAAP adjustments.

 

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

5


 


 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)

(unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

Three months ended September 30, 2016

 

GAAP

 

Share-based
Compensation

 

Amortization

 

Other

 

Non-GAAP

 

Net sales

 

$

85,482

 

 

 

 

 

 

 

$

85,482

 

Gross profit

 

33,455

 

607

 

 

 

355

 

34,417

 

Gross margin

 

39.1

%

 

 

 

 

 

 

40.3

%

Research and development

 

19,892

 

(993

)

 

 

 

 

18,899

 

Selling, general, and administrative and Other

 

19,191

 

(2,143

)

 

 

(1,368

)

15,680

 

Net income (loss)

 

(69,598

)

3,743

 

5,261

 

58,831

 

(1,763

)

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(1.78

)

 

 

 

 

 

 

$

(0.05

)

Diluted

 

(1.78

)

 

 

 

 

 

 

(0.05

)

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

39,131

 

 

 

 

 

 

 

39,131

 

Diluted

 

39,131

 

 

 

 

 

 

 

39,131

 

 

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30, 2016

 

 

 

Asset impairment

 

56,035

 

Restructuring

 

1,798

 

Acquisition related

 

63

 

Accelerated depreciation

 

355

 

Pension termination

 

1,305

 

Non-GAAP tax adjustment *

 

(725

)

Total Other

 

58,831

 

 


* - The ‘with or without’ method is utilized to determine the income tax effect of all non-GAAP adjustments.

 

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

6



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)

(in thousands)

(unaudited)

 

 

 

Three months ended

 

Three months ended

 

 

 

September 30, 2017

 

September 30, 2016

 

GAAP Net income (loss)

 

$

(21,884

)

$

(69,598

)

Share-based compensation

 

6,170

 

3,743

 

Amortization

 

12,500

 

5,261

 

Restructuring

 

4,143

 

1,798

 

Acquisition related

 

783

 

63

 

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

1,856

 

 

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

293

 

 

Accelerated depreciation

 

 

355

 

Asset impairment

 

2

 

56,035

 

Pension termination

 

 

1,305

 

Interest (income) expense

 

4,748

 

(260

)

Income tax expense (benefit)

 

(1,790

)

1,136

 

Non-GAAP Operating Income (loss)

 

$

6,821

 

$

(162

)

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

7



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in millions, except per share amounts)

(unaudited)

 

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

 

Guidance for the three months ended December 31, 2017

 

GAAP

 

Share-based
Compensation

 

Amortization

 

Other

 

Non-GAAP

 

Net sales

 

$

135

 

$

155

 

 

 

 

 

 

 

135

 

155

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

52

 

63

 

1

 

 

 

53

 

64

 

Gross margin

 

39

%

41

%

 

 

 

 

 

 

39

%

41

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(15

)

$

(8

)

5

 

12

 

(2

)

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per diluted common share

 

$

(0.33

)

$

(0.17

)

 

 

 

 

 

 

$

 

$

0.16

 

Weighted average number of shares

 

47

 

 

47

 

 

 

 

 

 

 

47

 

 

47

 

 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)

(in millions)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Guidance for the three months ended December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

$

(15

)

$

(8

)

Share-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

5

 

5

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

12

 

12

 

Restructuring

 

 

 

 

 

 

 

 

 

 

 

 

1

 

1

 

Acquisition related

 

 

 

 

 

 

 

 

 

 

 

 

1

 

1

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

 

5

 

5

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

(4

)

(4

)

Non-GAAP Operating Income

 

 

 

 

 

 

 

 

 

 

 

 

$

5

 

$

12

 

 

Note:  Amounts may not calculate precisely due to rounding.

 

These table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

8